Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 38Thoracic 1Gynecologic 1

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 18Colorectal Neoplasms 10Stomach Neoplasms 9Fallopian Tube Neoplasms 8Endometrial Neoplasms 8Colonic Neoplasms 7Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Renal Cell 4Appendiceal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Pseudomyxoma Peritonei 2Prostatic Neoplasms 2Neuroblastoma 2Melanoma 2Lung Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Breast Neoplasms 2

Interventions

pembrolizumab 6Nivolumab 3Cisplatin 3Carboplatin 3Paclitaxel 2Fluorouracil 2tucatinib 1pertuzumab 1milademetan 1lenvatinib 1cemiplimab 1Trastuzumab 1Tomography, X-Ray Computed 1Ritonavir 1Radiation 1Prednisone 1Prednisolone 1Positron-Emission Tomography 1Pemetrexed 1Oxaliplatin 1Magnetic Resonance Imaging 1Leucovorin 1Itraconazole 1Gemcitabine 1Fulvestrant 1Cetuximab 1Capecitabine 1Brachytherapy 1Bevacizumab 1AZD9833 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Oxaliplatin × Gynecologic × Clear all
NCT03314935 2025-08-12

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Incyte Corporation

Phase 1/2 Completed
149 enrolled 35 charts
GastrointestinalGynecologic

Biliary Tract Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡